James D. Brooks

Academic Appointments
Appointment
Organization
Associate Professor
Member
Member
Clinical Specialties
Urologic Oncology: Prostate Cancer, Urologic Cancers; Male Cancers - Prostate  

View Clinical Profile
Graduate & Fellowship Program Affiliations
 
Honors & Awards
Title
Organization
Date(s)
Dornier Research Scholar
American Foundation for Urologic Disease
1995-1997
Clinician Scientist Award
Doris Duke Foundation
1998-2002
Eugene P. Schonfeld Medical Research Award
Kidney Cancer Association
2000-2002
Leutje-Stubbs Faculty Scholar
Stanford University School of Medicine
2002-2003
Administrative Appointments
Title
Organization
Start Year
End Year
Membership Committee
Society for Basic Urologic Research
2004
-
Editorial Board
The Prostate
2000
-
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
A. B.
University of Chicago
Biology
1982
M. D.
Stanford University
Medicine
1988
Research Interests

We have identified a genetic change common to all human prostate cancer - loss of expression of glutathione S-transferase-pi (GSTP1). Loss of expression is associated with extensive hypermethylation of deoxycytidine residues in 5'-regulatory sequences. Since GSTP1 is involved in defense against carcinogens, we are exploring induction of other carcinogen defense enzymes as a potential prostate cancer prevention strategy. Recently, we have identified several candidate phase 2 enzyme inducing agents that are effective in the prostate. We have used comprehensive gene expression profiling (DNA microarrays) to identify the mechanisms of action of some of these agents, and of other candidate prostate cancer preventive compounds. We have also used gene expression profiling to investigate the transciptional and DNA copy-number changes that occur in prostate and kidney cancer. We are using these large datasets to identify novel diagnostic and prognostic markers for these diseases. We have ongoing projects that correlate gene expression changes with the clinical features of the cancers.

Publications
  • Lapointe J, Malhotra S, Higgins JP, Bair E, Thompson M, Salari K, Giacomini CP, Ferrari M, Montgomery K, Tibshirani R, van de Rijn M, Brooks JD, Pollack JR "hCAP-D3 Expression Marks a Prostate Cancer Subtype With Favorable Clinical Behavior and Androgen Signaling Signature." Am J Surg Pathol 2008; 32: 2: 205-209 More »
  • Thompson M, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, Pollack JR "Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle." Prostate 2008; More »
  • Zhao H, Brooks JD "Selenomethionine induced transcriptional programs in human prostate cancer cells." J Urol 2007; 177: 2: 743-50 More »
  • Lapointe J, Kim YH, Miller MA, Li C, Kaygusuz G, van de Rijn M, Huntsman DG, Brooks JD, Pollack JR "A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis." Mod Pathol 2007; More »
  • Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC, van de Rijn M, Brooks JD "Placental S100 (S100P) and GATA3: Markers for Transitional Epithelium and Urothelial Carcinoma Discovered by Complementary DNA Microarray." Am J Surg Pathol 2007; 31: 5: 673-680 More »
89 publications:   view full list